Time to SGLT2 Inhibitors Initiation in Patients With Heart Failure

Jungyeon Moon; Jacob A Udell; Alice Chong; Jiming Fang; Peter C Austin; Dennis T Ko; Therese A Stukel; Clare L Atzema; Gillian L Booth; Karen Tu; David M J Naimark; Cynthia A Jackevicius

doi:10.1161/JAHA.123.032296

Time to SGLT2 Inhibitors Initiation in Patients With Heart Failure

J Am Heart Assoc. 2024 Apr 16;13(8):e032296. doi: 10.1161/JAHA.123.032296. Epub 2024 Apr 2.

Authors

Jungyeon Moon¹, Jacob A Udell^{2

3

4}, Alice Chong⁴, Jiming Fang⁴, Peter C Austin^{3

4}, Dennis T Ko^{3

4

5}, Therese A Stukel^{3

4}, Clare L Atzema^{3

4

6}, Gillian L Booth^{3

4

7}, Karen Tu^{3

6

8

9}, David M J Naimark^{3

4

10}, Cynthia A Jackevicius^{1

3

4

11}

Affiliations

¹ College of Pharmacy Western University of Health Sciences Pomona CA USA.
² Cardiovascular Division, Department of Medicine Women's College Hospital and Peter Munk Cardiac Centre, Toronto General Hospital Toronto Ontario Canada.
³ University of Toronto Toronto Ontario Canada.
⁴ ICES Toronto Ontario Canada.
⁵ Schulich Heart Centre Sunnybrook Health Sciences Centre Toronto Ontario Canada.
⁶ Division of Emergency Medicine, Department of Medicine Sunnybrook Health Sciences Center Toronto Ontario Canada.
⁷ MAP Centre for Urban Health Solutions Li Ka Shing Knowledge Institute, St. Michael's Hospital Toronto Ontario Canada.
⁸ North York General Hospital Toronto Ontario Canada.
⁹ Toronto Western Hospital Family Health Team Network Toronto Ontario Canada.
¹⁰ Division of Nephrology, Department of Medicine Sunnybrook Health Sciences Centre Toronto Ontario Canada.
¹¹ Veterans Affairs Greater Los Angeles Healthcare System Los Angeles CA USA.

PMID: 38563368
DOI: 10.1161/JAHA.123.032296

No abstract available

Keywords: heart failure; initiation time; prescribing patterns; sodium‐glucose transporter 2 inhibitors.

MeSH terms

Diabetes Mellitus, Type 2*
Glucose
Heart Failure* / drug therapy
Humans
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Glucose